ESP vs RTX

ESP presents a dichotomy of strong current profitability and concerning forward-looking indicators. While the Piotroski F-Score of 4/9 indicates stable financial health and margins remain robust, the company is facing a revenue contraction of -10.8% YoY. Most critically, management has explicitly warned in the 10-K that net income per share is expected to decline in fiscal 2026 due to higher costs in the existing backlog. With heavy insider selling and a technical trend score of 10/100, the stock appears overextended relative to its defensive Graham value of $38.77.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.